Fig. 1 · Structure

Documents & Downloads

Gefitinib (ZD1839)

Cat. No. A10422 CAS 184475-35-2

EGFR Inhibitor

Gefitinib is an EGFR inhibitor, which interrupts signaling through the epidermal growth factor receptor (EGFR) in target cells.

In Stock

Publications for Gefitinib

2 publications citing this product

  1. Hamzehlou S, .et al. , Eur J Pharmacol, 2019, Nov 15;863:172705 PMID: 31574259
  2. Mansi Srivastava, .et al. , Int Immunopharmacol, 2019, 71: 188-197 PMID: 30909134

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Biological Activity

Target & Activity

Target Activity Value
Tyr1173 (NR6W cells) 26 nM
Tyr1173 (NR6wtEGFR cells) 37 nM
Tyr992 (NR6wtEGFR cells) 37 nM
Tyr992 (NR6W cells) 57 nM

Cellular Effect

Cell Line Activity Value Description Reference
16HBE14o- IC50 1.601 μM Antiproliferative activity against human 16HBE cells expressing wild type EGFR after 72 hrs by MTT assay [PMID: 23792318]
16HBE14o- IC50 12.71 μM Antiproliferative activity against human 16HBE cells after 72 hrs by MTT assay [PMID: 24607591]
16HBE14o- IC50 12.71 μM Cytotoxicity against human 16HBE14o- cells harboring wild type EGFR assessed as growth inhibition after 72 hrs by MTT assay [PMID: 23668441]
A-375 IC50 20.55 μM Antiproliferative activity against human A375 cells after 48 hrs by MTT assay [PMID: 20304537]
A-431 IC50 0.023 μM In vitro inhibitory activity against Epidermal growth factor receptor (EGFR-TK) from A431 vulval squamous carcinoma cells using TKI assay [PMID: 11459659]
A-431 GI50 0.514 μM Growth inhibition of human A431 cells after 72 hrs by MTT assay [PMID: 19969465]
A-431 IC50 0.55 μM Antiproliferative activity against human A431 cells overexpressing EGFR assessed as cell growth inhibition measured after 72 hrs by MTT assay [PMID: 32139324]
A-431 IC50 0.55 μM Cytotoxicity against human A431 cells overexpressing EGFR assessed as growth inhibition after 72 hrs by MTT assay [PMID: 27524310]
A-431 IC50 0.55 μM Cytotoxicity against human A431 cells expressing EGFR after 72 hrs by MTT assay [PMID: 24411123]
A-431 IC50 1.08 μM Inhibition of EGFR derived from human A431 cell membrane assessed as inhibition of poly-Glu-Tyr phosphorylation after 30 mins by ELISA assay [PMID: 22698782]
A-431 IC50 1.1 μM Inhibition of EGFR in shed membrane vesicles of human A431 cells using poly-Glu-Tyr as substrate after 30 mins by ELISA [PMID: 24094432]
A-431 IC50 1.282 μM Antiproliferative activity against human A431 cells harboring wild-type EGFR after 72 hrs by MTT assay [PMID: 30471829]
A-431 IC50 1.33 μM Antiproliferative activity against human A431 cells harboring wild type EGFR assessed as reduction in cell viability after 72 hrs by MTT assay [PMID: 26829280]
A-431 IC50 1.41 μM Antiproliferative activity against human A431 cells after 48 hrs by MTT assay [PMID: 22698782]
A-431 EC50 1.71 μM Antiproliferative activity against human A431 cells expressing wild type EGFR incubated for 96 hrs measured on day 5 by CellTiterGlo assay [PMID: 28853575]
A-431 IC50 1.89 μM Cytotoxicity against human A431 cells after 48 hrs by MTT assay 10.1007/s00044-013-0734-x
A-431 IC50 1.98 μM Antiproliferative activity against human A431 cells after 72 hrs by MTT assay [PMID: 24094432]
A-431 IC50 12.05 μM Cytotoxicity against EGFR overexpressing human A431 cells after 24 hrs by MTT assay [PMID: 18771819]
A-431 IC50 12.58 μM Antiproliferative activity against EGFR over-expressing human A431 cells after 48 hrs by MTT assay [PMID: 28236592]
A-431 IC50 16.02 μM Antiproliferative activity against human A-431 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay [PMID: 34147910]

20 records · Scroll to view more

Specifications

Manufacturer Adooq Bioscience
Actions Inhibitor
CAS Number 184475-35-2
Applications EGFR Inhibitor
Formula C22H24ClFN4O3
Molecular Weight 446.9
Synonyms ZD-1839; Iressa
SMILES
COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4

Storage & Solubility

In Vitro Solubility

Reported Solubility

SolventReported Solubility
DMSO 80 mg/mL (179 mM)
Water Insoluble
Ethanol 4 mg/mL (8.95 mM)

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

In Vivo Preparation

Concentration
28 mg/mL
Vehicle
1% CMC Na

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Publications

2 publications citing this product

  1. Hamzehlou S, .et al. , Eur J Pharmacol, 2019, Nov 15;863:172705 PMID: 31574259
  2. Mansi Srivastava, .et al. , Int Immunopharmacol, 2019, 71: 188-197 PMID: 30909134

Added to your cart

View Cart Checkout
Loading...